- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Baker Norton Pharmaceuticals
Total 299 results
-
BayerRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsBayerCompletedDiabetic Macular EdemaUnited States
-
Regeneron PharmaceuticalsBayerCompletedNeovascular Age-related Macular DegenerationUnited States, Canada
-
BayerRegeneron PharmaceuticalsCompletedMacular DegenerationBelgium, Israel, Italy, Spain, Korea, Republic of, Switzerland, Germany, Portugal, Japan, France, Australia, Netherlands, India, Austria, Brazil, Poland, United Kingdom, Singapore, Hungary, Latvia, Mexico, Czech Republic, Colombia, Ar... and more
-
Regeneron PharmaceuticalsBayerCompletedBranch Retinal Vein OcclusionUnited States, Japan, Canada
-
BayerRegeneron PharmaceuticalsCompleted
-
BayerNovartis PharmaceuticalsCompletedPulmonary Disease, Chronic ObstructiveGermany
-
BayerUltragenix pharmaceuticalActive, not recruitingHemophilia ANetherlands, United States, Germany, United Kingdom, France, Bulgaria
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Boston PharmaceuticalsCompletedSystemic Lupus ErythematosusUnited States, Philippines, Hungary, Poland, Mexico, Colombia, Ukraine, Peru, Romania, Argentina, Bulgaria, Georgia
-
Boston PharmaceuticalsCompletedDiarrhea-predominant Irritable Bowel SyndromeUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Boston PharmaceuticalsCompletedHealthy ParticipantsUnited States
-
Boston PharmaceuticalsCompleted
-
Boston PharmaceuticalsCompleted
-
Boston PharmaceuticalsCompleted
-
Boston UniversityTakeda Pharmaceuticals North America, Inc.CompletedIrritable Bowel Syndrome
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
Boston PharmaceuticalsCompletedChronic Plaque PsoriasisGermany
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Spain
-
Spectrum Pharmaceuticals, IncBayerTerminatedLymphoma, Large Cell, DiffuseSweden, United States, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Poland, Finland, Canada, France, Germany, Portugal, Thailand, Belgium, Austria, Ireland, Singapore, Switzerland
-
Novartis PharmaceuticalsBayerCompletedColorectal Neoplasms | Rectal Neoplasms | Colonic NeoplasmsUnited States, Germany, Belgium, Canada, Spain, United Kingdom, Taiwan, France, Switzerland, Sweden, Portugal, New Zealand, Italy, Slovakia, Australia, Austria, Brazil, Hong Kong
-
Spectrum Pharmaceuticals, IncBayerCompleted
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Canada
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
BayerOrion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaBayerCompleted
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
BayerOrion Corporation, Orion PharmaCompletedHepatic Insufficiency | Renal Insufficiency | PharmacokineticsGermany
-
BayerOrion Corporation, Orion PharmaCompletedBiological AvailabilityGermany
-
BayerSATO PHARMACEUTICAL , Ltd.Completed
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
Woman'sBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedPolycystic Ovary SyndromeUnited States
-
UMC UtrechtBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompleted
-
BayerTAP Pharmaceutical Products Inc.Completed
-
University of LouisvilleNorton Healthcare; Cumberland PharmaceuticalsCompletedAutism | Severe Behavior DisorderUnited States
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Novartis PharmaceuticalsBaker Heart and Diabetes InstituteCompletedHypertensionUnited States, Australia
-
Boston UniversityRegeneron PharmaceuticalsCompletedSystemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse SclerodermaUnited States
-
Boston UniversityAspreva PharmaceuticalsCompleted
-
Thomas Jefferson UniversityBayer; Novartis PharmaceuticalsActive, not recruitingDifferentiated Thyroid CancerUnited States
-
OncoMed Pharmaceuticals, Inc.BayerCompleted
-
NYU Langone HealthBayer; OSI PharmaceuticalsCompletedPancreatic CancerUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
University of WashingtonBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedHepatocellular Carcinoma
-
US Oncology ResearchBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedColorectal Neoplasms | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedneurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade GliomaUnited States
-
Derm Research, PLLCBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedAcne RosaceaUnited States
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompleted